ATE554066T1 - Entzündungshemmende substituierte cyclobutendionverbindungen - Google Patents

Entzündungshemmende substituierte cyclobutendionverbindungen

Info

Publication number
ATE554066T1
ATE554066T1 AT08760484T AT08760484T ATE554066T1 AT E554066 T1 ATE554066 T1 AT E554066T1 AT 08760484 T AT08760484 T AT 08760484T AT 08760484 T AT08760484 T AT 08760484T AT E554066 T1 ATE554066 T1 AT E554066T1
Authority
AT
Austria
Prior art keywords
compounds
cyclobutendione
inflammatory
substituted
inflammatory substituted
Prior art date
Application number
AT08760484T
Other languages
English (en)
Inventor
Neil John Press
Simon James Watson
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of ATE554066T1 publication Critical patent/ATE554066T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/14Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT08760484T 2007-06-06 2008-06-04 Entzündungshemmende substituierte cyclobutendionverbindungen ATE554066T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07109704 2007-06-06
PCT/EP2008/056902 WO2008148790A1 (en) 2007-06-06 2008-06-04 Anti -inflammatory substituted cyclobutenedione compounds

Publications (1)

Publication Number Publication Date
ATE554066T1 true ATE554066T1 (de) 2012-05-15

Family

ID=38626949

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08760484T ATE554066T1 (de) 2007-06-06 2008-06-04 Entzündungshemmende substituierte cyclobutendionverbindungen

Country Status (13)

Country Link
US (1) US8183281B2 (de)
EP (1) EP2155670B1 (de)
JP (1) JP2010529079A (de)
KR (1) KR20100031718A (de)
CN (1) CN101772485A (de)
AT (1) ATE554066T1 (de)
AU (1) AU2008258588B2 (de)
BR (1) BRPI0812222A2 (de)
CA (1) CA2689581A1 (de)
EA (1) EA200901612A1 (de)
ES (1) ES2386489T3 (de)
MX (1) MX2009013276A (de)
WO (1) WO2008148790A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA103198C2 (en) 2008-08-04 2013-09-25 Новартис Аг Squaramide derivatives as cxcr2 antagonists
US8648070B2 (en) 2010-12-17 2014-02-11 Boehringer Ingelheim International Gmbh Bicyclic ring system substituted sulfonamide functionalised phenols as medicaments
US8648118B2 (en) 2010-12-17 2014-02-11 Boehringer Ingelheim International Gmbh Bicyclic ring system substituted amide functionalised phenols as medicaments
SI2760821T1 (en) 2011-09-02 2018-02-28 Novartis Ag A salt salt of an anti-inflammatory substituted cyclobutenedione compound
FR2981935B1 (fr) * 2011-10-28 2015-08-07 Galderma Res & Dev Nouveaux composes di-substitues de la diamino-3,4-cyclobutene-3-dione-1,2 utiles dans le traitement de pathologies mediees par des chimiokines.
FR2981934B1 (fr) * 2011-10-28 2013-12-20 Galderma Res & Dev Nouveaux composes di-substitues de la diamino-3,4-cyclobutene-3-dione-1,2 utiles dans le traitement de pathologies mediees par des chimiokines.
CZ305626B6 (cs) * 2014-05-09 2016-01-13 Vysoká škola chemicko- technologická v Praze Dioxocyklobutenylhydrazony a jejich protirakovinné účinky
FR3030515B1 (fr) 2014-12-23 2017-01-20 Galderma Res & Dev Nouveaux composes antagonistes des recepteurs cxcr1 et cxcr2 aux chimiokines, et leur utilisation dans le traitement de pathologies mediees par des chimiokines
TWI734715B (zh) 2015-11-19 2021-08-01 美商卡默森屈有限公司 趨化因子受體調節劑
TWI724056B (zh) 2015-11-19 2021-04-11 美商卡默森屈有限公司 Cxcr2抑制劑
JP2020530848A (ja) * 2017-08-14 2020-10-29 アラーガン、インコーポレイテッドAllergan,Incorporated 3,4−二置換3−シクロブテン−1,2−ジオンおよびその使用
MA50424A (fr) 2018-01-08 2020-08-26 Chemocentryx Inc Méthodes de traitement du psoriasis pustuleux généralisé avec un antagoniste de ccr6 ou cxcr2
PE20211070A1 (es) 2018-09-21 2021-06-09 Pfizer Dioxociclobutenilamino-3-hidroxi-picolinamidas n-sustituidas utiles como inhibidores de ccr6
CN109824629B (zh) * 2019-02-27 2022-12-09 南京工业大学 一种利用N-乙酰氨基葡萄糖制备3-氨基-5-(α-氨基乙基)四氢呋喃的方法
UY38860A (es) 2019-08-28 2021-02-26 Novartis Ag Derivados de 1,3–fenil heteroarilo sustituidos, composiciones para su uso en el tratamiento de enfermedades y formas cristalinas
CN112759549B (zh) * 2019-11-05 2023-07-28 中国医学科学院药物研究所 3-取代氨基-4-((取代吡啶基)氨基)环丁-3-烯-1,2-二酮类化合物
CN112851635B (zh) * 2019-11-28 2022-09-16 中国医学科学院药物研究所 环状砜类化合物及其制备方法、用途和药物组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6166050A (en) 1998-12-14 2000-12-26 American Home Products Corporation 3,4-diamino-3-cyclobutene-1,2-dione derivatives which inhibit leukocyte adhesion mediated by VLA-4
EP1351933B1 (de) 2001-01-16 2006-11-22 SmithKline Beecham Corporation Il-8-rezeptorantagonisten
ES2287284T3 (es) 2001-04-16 2007-12-16 Schering Corporation Ciclobuteno-1,2-dionas disustituidas en las posiciones 3,4 como ligandos de receptores de quimiocinas cxc.
US20040106794A1 (en) 2001-04-16 2004-06-03 Schering Corporation 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
US7132445B2 (en) 2001-04-16 2006-11-07 Schering Corporation 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
US20040053953A1 (en) 2002-03-18 2004-03-18 Schering Corporation Treatment of chemokine mediated diseases

Also Published As

Publication number Publication date
BRPI0812222A2 (pt) 2014-12-16
AU2008258588A8 (en) 2010-05-13
WO2008148790A8 (en) 2010-01-07
CN101772485A (zh) 2010-07-07
KR20100031718A (ko) 2010-03-24
AU2008258588B2 (en) 2011-11-10
AU2008258588A1 (en) 2008-12-11
EA200901612A1 (ru) 2010-06-30
WO2008148790A1 (en) 2008-12-11
US8183281B2 (en) 2012-05-22
EP2155670A1 (de) 2010-02-24
MX2009013276A (es) 2010-01-25
EP2155670B1 (de) 2012-04-18
ES2386489T3 (es) 2012-08-21
JP2010529079A (ja) 2010-08-26
CA2689581A1 (en) 2008-12-11
US20100125071A1 (en) 2010-05-20

Similar Documents

Publication Publication Date Title
ATE554066T1 (de) Entzündungshemmende substituierte cyclobutendionverbindungen
CY1119515T1 (el) Οξαζολο υποκατεστημενα ινδαζολια ως αναστολεις ρι3-κινασης
CO6491116A2 (es) Derivados de 5-fluoropirimidinona
ECSP10010722A (es) Compuestos orgánicos
CR11021A (es) Derivados de quinolina como fungicidas
UA107791C2 (en) Pesticidal compositions
CY1109911T1 (el) Πυρρολοβενζοδιαζεπινες
EA201000395A1 (ru) Фунгицидные производные 2-алкилтио-2-хинолинилоксиацетамида
EA201070519A1 (ru) Соединения тропана
EA201100875A1 (ru) Новые пиразол-4-n-алкоксикарбоксамиды в качестве микробиоцидов
EA201170132A1 (ru) 5-гетероциклилалкил-3-гидрокси-2-фенилциклопент-2-еноны в качестве гербицидов
EA200870514A1 (ru) Ацетиленовые гетероарильные соединения
EA201270256A1 (ru) Производные т1-замещенного 5-фтор-2-оксопиримидинон-1 (2h) -карбоксамида
EA201101148A1 (ru) Новые гербициды
EA201101099A1 (ru) Гербициды, полученные из циклопентадиона
EA201101060A1 (ru) Новые гербициды
UA106880C2 (uk) Нові гербіциди
EA201101146A1 (ru) Новые гербициды
UA106889C2 (uk) Похідні n1-ацил-5-фторпіримідинону
UY31688A1 (es) Plaguicidas
ATE483000T1 (de) Naphtalin-amidin-imide
EA201101097A1 (ru) Новые микробиоциды
EA201000069A1 (ru) Новые гербициды
DE602006009789D1 (de) Acetylenderivate
EA200801366A1 (ru) Производные 3,6-дигидро-2-оксо-6н-1,3,4-тиадиазина